Age associated with mortality in PMP HER2+ women with breast cancer
Posted on Mon, Feb 20, 2012
As published in
JAMA, postmenopausal HER2+ women with breast cancer had increased disease-specific mortality and relapse as a function of age. Specifically, compared with women < 65 years of age, women 65-74 and
> 75 years of age had HRs of 1.25 and 1.63, respectively.